Literature DB >> 1733931

Insertional mutagenesis of Bordetella pertussis adenylate cyclase.

D Ladant1, P Glaser, A Ullmann.   

Abstract

We developed an improved method of linker insertion mutagenesis for introducing 2 or 16 codons into the Bordetella pertussis cyaA gene which encodes a calmodulin-dependent adenylate cyclase. A recombinant kanamycin resistance cassette, containing oligonucleotide linkers, was cloned in plasmids which carried a truncated cyaA gene, fused at its 3' end to the 5' end of the Escherichia coli lacZ gene, specifying the alpha-peptide. This construction permitted a double selection for in-frame insertions by using screening for kanamycin resistance and for lactose-positive phenotype, resulting from alpha-complementation. We showed that most of the two-amino acid insertions within the N-terminal moiety of the catalytic domain of adenylate cyclase abolished enzymatic activity and/or altered the stability of the protein. All two-amino acid insertions within the C-terminal part of adenylate cyclase resulted in fully stable and active enzymes. These results confirm the modular structure of the catalytic domain of adenylate cyclase, previously proposed on the basis of proteolytic studies. Two-amino acid insertions between residues 247-248 and 335-336 were shown to affect the calmodulin responsiveness of adenylate cyclase, suggesting that the corresponding region in the enzyme is involved in the binding of calmodulin or in the process of calmodulin activation. In addition, we have identified within the primary structure of adenylate cyclase several permissive sites which tolerate 16-amino acid insertions without interfering with the catalytic activity or calmodulin binding. By inserting foreign antigenic determinants into these permissive sites the resulting recombinant adenylate cyclase toxin could be used to deliver specific epitopes into antigen-presenting cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733931

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites.

Authors:  R Osicka; A Osicková; T Basar; P Guermonprez; M Rojas; C Leclerc; P Sebo
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

2.  Efficient display of two enzymes on filamentous phage using an improved signal sequence.

Authors:  Heike Strobel; Daniel Ladant; Jean-Luc Jestin
Journal:  Mol Biotechnol       Date:  2003-05       Impact factor: 2.695

3.  The Bacillus licheniformis BlaP beta-lactamase as a model protein scaffold to study the insertion of protein fragments.

Authors:  Marylène Vandevenne; Patrice Filee; Natacha Scarafone; Benoît Cloes; Gilles Gaspard; Nursel Yilmaz; Mireille Dumoulin; Jean-Marie François; Jean-Marie Frère; Moreno Galleni
Journal:  Protein Sci       Date:  2007-10       Impact factor: 6.725

4.  A bacterial two-hybrid system based on a reconstituted signal transduction pathway.

Authors:  G Karimova; J Pidoux; A Ullmann; D Ladant
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

5.  Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cells.

Authors:  P Sebo; C Fayolle; O d'Andria; D Ladant; C Leclerc; A Ullmann
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

6.  Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus.

Authors:  M F Saron; C Fayolle; P Sebo; D Ladant; A Ullmann; C Leclerc
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

7.  The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin.

Authors:  F Betsou; P Sebo; N Guiso
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Suppression of T-lymphocyte activation and chemotaxis by the adenylate cyclase toxin of Bordetella pertussis.

Authors:  Silvia Rossi Paccani; Federica Dal Molin; Marisa Benagiano; Daniel Ladant; Mario M D'Elios; Cesare Montecucco; Cosima T Baldari
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

9.  Pore-forming and enzymatic activities of Bordetella pertussis adenylate cyclase toxin synergize in promoting lysis of monocytes.

Authors:  Marek Basler; Jiri Masin; Radim Osicka; Peter Sebo
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

10.  An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.

Authors:  Laleh Majlessi; Marcela Simsova; Zdenka Jarvis; Priscille Brodin; Marie-Jésus Rojas; Cécile Bauche; Clémence Nouzé; Daniel Ladant; Stewart T Cole; Peter Sebo; Claude Leclerc
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.